Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05036707 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Human Immune Response to Ixodes Scapularis Tick Bites

StatusRecruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Jun 30, 2028 → Jun 30, 2029
See other at-risk trials from National Institute of Allergy and Infectious Diseases (NIAID)

Record History

  1. Minor Re-verified, no change to tracked fields
  2. Notable Primary and study completion pushed from Jun 30, 2028 to Jun 30, 2029 Eligibility criteria expanded, about 46 words · Study description expanded, about 22 words · Publications: details revised at 3 of 3 entries Show 3 more changesShow less
    • Eligibility criteria expanded, about 46 words
    • Study description expanded, about 22 words
    • Publications: details revised at 3 of 3 entries
  3. Notable Primary and study completion pushed from Jun 30, 2026 to Jun 30, 2028v26
  4. Minor 2 versions Re-verified since May 17, 2025, no change to tracked fieldsv24-v25
  5. Notable Primary and study completion dates: Jun 30, 2025 to Jun 30, 2026v23
Show 21 earlier versionsHide 21 earlier versions
  1. Minor 3 versions Re-verified since Jul 31, 2024, no change to tracked fieldsv20-v22
  2. Minor Study description expanded, about 32 words Eligibility criteria expanded, about 5 wordsv19 Show 1 more changeShow less
    • Eligibility criteria expanded, about 5 words

    See this version in full on ClinicalTrials.gov ↗

  3. Notable Primary and study completion dates: Jun 30, 2024 to Jun 30, 2025v18
  4. Minor 4 versions Re-verified since Aug 16, 2023, no change to tracked fieldsv14-v17
  5. Notable Primary completion date: Jun 30, 2023 to Jun 30, 2024v13
  6. Minor Re-verified, no change to tracked fieldsv12
  7. Minor Completion date: Jun 30, 2023 to Jun 30, 2024 Study description expanded, about 2 wordsv11 Show 1 more changeShow less
    • Study description expanded, about 2 words

    See this version in full on ClinicalTrials.gov ↗

  8. Minor 5 versions Re-verified since Mar 8, 2023, no change to tracked fieldsv6-v10
  9. Minor Study description revisedv5 See this version in full on ClinicalTrials.gov ↗
  10. Minor Re-verified, no change to tracked fieldsv4
  11. Notable Start date changed from estimate of Sep 14, 2021 to Feb 28, 2022 Eligibility criteria expanded, about 21 words · Study description expanded, about 685 wordsv3 Show 2 more changesShow less
    • Eligibility criteria expanded, about 21 words
    • Study description expanded, about 685 words

    See this version in full on ClinicalTrials.gov ↗

  12. Minor Start date: Sep 13, 2021 to Sep 14, 2021v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: Each year, the number of cases of tick-borne diseases increases. The deer tick (Ixodes scapularis) is the vector of at least 7 pathogens that cause human diseases, including Lyme disease. Researchers want to learn more to help them develop vaccines against ticks in the future. Objective: To learn how people s bodies, particularly the skin, respond to tick bites. Eligibility: Healthy adults aged 18 years and older who have no known history of a tick-borne disease or tick bite exposure. Design: Participants will be screened with a medical history, physical exam, and blood tests. Participants will have 2 skin punch biopsies of healthy skin. For this, a sharp instrument will be used to remove a round plug of skin about the size of a pencil eraser. Participants will then have 10 clean laboratory-bred ticks placed at 2 different sites on their skin (20 ticks total). The ticks will be removed from the first site 1 day after placement and from the second site 2-4 days after placement. Participants will complete symptom diary cards. They will answer questions about itching at the tick feeding sites. They will give blood samples. Photos will be taken of the tick feeding sites. Skin punch biopsies will be collected at the sites of the tick bites. Participants will repeat the tick feeding procedures 2 times, each 2-8 weeks apart. For the 2nd and 3rd procedures, 10 clean laboratory-bred ticks will be placed at 1 site. The ticks will be removed 2-3 days after tick placement. They will have telephone follow-up visits after each procedure. After the final tick removal, participants will have follow-up visits in 4-6 weeks and again in 3 months. They will give blood samples and discuss how they are feeling. Participation will last about 5-7 months.
Trial Details
NCT Number NCT05036707
Lead Sponsor National Institute of Allergy and Infectious Diseases (NIAID)
Conditions Tick-borne Diseases, Tick Resistance, Lyme Disease
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov